<DOC>
	<DOCNO>NCT00763672</DOCNO>
	<brief_summary>The purpose study determine whether close monitoring patient high sFlt1 plasma level 25 28 week gestation ( i.e . high risk subsequent preeclampsia ) improve maternal fetal outcome . The investigator hypothesize 1/ early screening preeclampsia plasmatic sFlt1 reduce maternal fetal mortality morbidity 2/ simple urinary PlGF screen effective .</brief_summary>
	<brief_title>MorbiMortality Amelioration Preeclamptic Primiparas Study . MoMA Pre Prim Study</brief_title>
	<detailed_description>We measure plasmatic sFlt-1 level 25 28 week gestation flow velocity uterine artery Doppler ( 22 - 26 week gestation ) primipara . Patients stratify accord result uterine artery Doppler measurement , randomize two group A B . In group A , sFlt-1 concentration communicate obstetrician ( + - ) : threshold abnormally high plasmatic concentration sFlt-1 957 ng/mL . In patient high plasmatic concentration sFlt-1 ( + ) , pregnancy closely monitor include repeat clinical , biological , ultrasound examination . Patients sFlt-1 plasmatic concentration 957 ng/mL ( - ) routinely followed-up.In group B , result sFlt-1 measurement communicate pregnancy routinely monitored.Abnormal Doppler recording either group result close monitoring per usual local practice . Urinary PlGF ( express ratio PlGF/creatininemia ) also measure result analyze end study . Beside sFlt-1 , store plasmatic sample measure biomarkers could relevant future ( DNA analysis do without new patient consent ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Pregnant womenAge â‰¥ 18 year Followed center 28th week gestation Under social security coverage Signed informed consent Age &lt; 18 year Followed center 28th week gestation No social security coverage Refusal include</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Preeclampsia</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Intra uterine growth retardation</keyword>
	<keyword>Antiangiogenic factor</keyword>
	<keyword>Prevention</keyword>
</DOC>